Emerging within the medical landscape, retatrutide appears a significant advance in the therapy arena . This novel dual activator targeting both GLP-1 and GIP receptors exhibits impressive results in research trials , retatrutide legal suggesting a improved ability to facilitate body reduction and address associated cardiovascular risks . While yet